Mar 21, 2017 11:02 am UTC| Business
OKLAHOMA CITY, March 21, 2017 -- Mammoth Energy Services, Inc. ("Mammoth" or the "Company") (NASDAQ:TUSK) announced today that it has entered into definitive agreements to acquire Sturgeon Acquisitions, LLC (which owns...
Mar 21, 2017 11:02 am UTC| Business
OKLAHOMA CITY, March 21, 2017 -- Mammoth Energy Services, Inc. ("Mammoth" or the "Company") (NASDAQ:TUSK) announced today that it has entered into definitive agreements to acquire Sturgeon Acquisitions, LLC (which owns...
Mar 21, 2017 11:02 am UTC| Business
- EMA guidance provides clear regulatory pathway for EU approval for Iomab-B - Trial design, primary endpoint and planned statistical analysis from the Iomab-B U.S. pivotal Phase 3 SIERRA trial are acceptable as the...
Mar 21, 2017 11:02 am UTC| Business
- EMA guidance provides clear regulatory pathway for EU approval for Iomab-B - Trial design, primary endpoint and planned statistical analysis from the Iomab-B U.S. pivotal Phase 3 SIERRA trial are acceptable as the...
Mar 21, 2017 11:02 am UTC| Business
- EMA guidance provides clear regulatory pathway for EU approval for Iomab-B - Trial design, primary endpoint and planned statistical analysis from the Iomab-B U.S. pivotal Phase 3 SIERRA trial are acceptable as the...
OncoCyte Submits Application for CLIA Certification of its Laboratory
Mar 21, 2017 11:02 am UTC| Business
ALAMEDA, Calif., March 21, 2017 -- OncoCyte Corporation (NYSE MKT:OCX), a developer of novel, non-invasive blood based tests to aid in the early detection of cancer, has submitted its application for CLIA certification...
OncoCyte Submits Application for CLIA Certification of its Laboratory
Mar 21, 2017 11:02 am UTC| Business
ALAMEDA, Calif., March 21, 2017 -- OncoCyte Corporation (NYSE MKT:OCX), a developer of novel, non-invasive blood based tests to aid in the early detection of cancer, has submitted its application for CLIA certification...